Differential diagnosis of trichosporonosis using conventional histopathological stains and electron microscopy

Histopathology

Volumn 56, Issue 3, 2010, Pages 372-383

  Obana, Yukari ^a   Sano, Makoto ^a   Jike, Toyoharu ^b   Homma, Taku ^a   Nemoto, Norimichi ^a  

^a NIHON UNIVERSITY   (Japan)

^b Nihon University   (Japan)

Author keywords

Electron microscopy; Glucuronoxylomannan; Histopathological stains; Pathological diagnosis; Trichosporonosis

Indexed keywords

ALCIAN BLUE; FERRIC HYDROXIDE; METHENAMINE PERIODATE SILVER; SILVER DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS; AUTOPSY; CANDIDA; CANDIDIASIS; CELL DENSITY; CELL WALL; COMPARATIVE STUDY; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS; DIFFERENTIAL DIAGNOSIS; DILUTION; ELECTRON MICROSCOPY; FUNGAL DETECTION; FUNGUS HYPHAE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; METHODOLOGY; MYCOSIS; NONHUMAN; POPULATION; PRIORITY JOURNAL; STAINING; TRICHOSPORONOSIS;

ASPERGILLOSIS; CANDIDIASIS; CRYPTOCOCCOSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MYCOSES; STAINING AND LABELING; TRICHOSPORON;

CANDIDA; FUNGI; TRICHOSPORON (UNCLASSIFIED);

EID: 77449145340     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03477.x     Document Type: Article

References (34)

1. Middelhoven WJ. Identification of clinically relevant Trichosporon species. Mycoses 2003 46 7 11.
2. Abdala E, Lopes RI, Chaves CN et al. Trichosporon asahii fatal infection in a non-neutropenic patient after orthotopic liver transplantation. Transpl. Infect. Dis. 2005 7 162 165.
3. Haupt HM, Merz WG, Beschorner WE et al. Colonization and infection with Trichosporon species in the immunosuppressed host. J. Infect. Dis. 1983 147 199 203.
4. Tashiro T, Nagai H, Nagaoka H et al. Trichosporon beigelii pneumonia in patients with hematologic malignancies. Chest 1995 108 190 195.
5. Erer B, Galimberti M, Lucarelli G et al. Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts. Bone Marrow Transplant. 2000 25 745 749.
6. Girmenia C, Pagano L, Martino B et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J. Clin. Microbiol. 2005 43 1818 1828.
7. Kontoyiannis DP, Torres HA, Chagua M et al. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand. J. Infect. Dis. 2004 36 564 569.
8. Krcmery V Jr., Mateicka F, Kunova A et al. Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol. Support. Care Cancer 1999 7 39 43.
9. Krcmery V Jr., Oravcova E, Spanik S et al. Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. J. Antimicrob. Chemother. 1998 41 373 380.
10. Sugita T, Nakajima M, Ikeda R et al. A nested PCR assay to detect DNA in sera for the diagnosis of deep-seated trichosporonosis. Microbiol. Immunol. 2001 45 143 148.
11. Antachopoulos C, Papakonstantinou E, Dotis J et al. Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole. J. Pediatr. Hematol. Oncol. 2005 27 283 285.
12. Asada N, Uryu H, Koseki M et al. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia. Clin. Infect. Dis. 2006 43 e39 e41.
13. Falk R, Wolf DG, Shapiro M et al. Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole. J. Clin. Microbiol. 2003 41 911.
14. Paphitou NI, Ostrosky-Zeichner L, Paetznick VL et al. In vitro antifungal susceptibilities of Trichosporon species. Antimicrob. Agents Chemother. 2002 46 1144 1146.
15. Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J. Clin. Microbiol. 2004 42 4419 4431.
16. Matsue K, Uryu H, Koseki M et al. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. Clin. Infect. Dis. 2006 42 753 757.
17. Bayramoglu G, Sonmez M, Tosun I et al. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin. Infection 2008 36 68 70.
18. Fukuzawa M, Inaba H, Hayama M et al. Improved detection of medically important fungi by immunoperoxidase staining with polyclonal antibodies. Virchows Arch. 1995 427 407 414.
19. Jensen HE, Schonheyder HC, Hotchi M et al. Diagnosis of systemic mycoses by specific immunohistochemical tests. APMIS 1996 104 241 258.
20. Kimura M, Takahashi H, Satou T et al. An autopsy case of disseminated trichosporonosis with candidiasis of the urinary bladder. Virchows Arch. A Pathol. Anat. Histopathol. 1989 416 159 162.
21. Nasu K, Akizuki S, Yoshiyama K et al. Disseminated Trichosporon infection. A case report and immunohistochemical study. Arch. Pathol. Lab. Med. 1994 118 191 194.
22. Sano M, Sugitani M, Ishige T et al. Supplemental utility of nested PCR for the pathological diagnosis of disseminated trichosporonosis. Virchows Arch. 2007 451 929 935.
23. Koyanagi T, Nishida N, Osabe S et al. Autopsy case of disseminated Trichosporon inkin infection identified with molecular biological and biochemical methods. Pathol. Int. 2006 56 738 743.
24. Walsh TJ, Lee JW, Melcher GP et al. Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. J. Infect. Dis. 1992 166 121 133.
25. Depree J, Emerson GW, Sullivan PA. The cell wall of the oleaginous yeast Trichosporon cutaneum. J. Gen. Microbiol. 1993 139 2123 2133.
26. Wessels JGH, Sietsma JH. Wall structure and growth in Schizophyllum commune. In Burnett JH, Trinci APJ eds. Fungal walls and hyphal growth: symposium of the British Mycological Society held at Queen Elizabeth College, London, April 197. Cambridge : Cambridge University Press, 1979 27 48.
27. Berkeley RCW. Chitin, chitosan and their degradative enzymes. In Berkeley RCW, Goody CW, Elwood DC eds. Microbial polysaccharide. New York : Academic Press, 1979 205 236.
28. Ichikawa T, Nishikawa A, Ikeda R et al. Structural studies of a cell wall polysaccharide of Trichosporon asahii containing antigen II. Eur. J. Biochem. 2001 268 5098 5106. (Pubitemid 32955561)
29. Shibata N, Suzuki A, Kobayashi H et al. Chemical structure of the cell-wall mannan of Candida albicans serotype A and its difference in yeast and hyphal forms. Biochem. J. 2007 404 365 372.
30. Fontaine T, Simenel C, Dubreucq G et al. Molecular organization of the alkali-insoluble fraction of Aspergillus fumigatus cell wall. J. Biol. Chem. 2000 275 27594 27607.
31. Dromer F, Salamero J, Contrepois A et al. Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide. Infect. Immun. 1987 55 742 748.
32. Inase N, Ohtani Y, Usui Y et al. Chronic summer-type hypersensitivity pneumonitis: clinical similarities to idiopathic pulmonary fibrosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2007 24 141 147.
33. Lyman CA, Devi SJ, Nathanson J et al. Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity. J. Clin. Microbiol. 1995 33 126 130.
34. Karashima R, Yamakami Y, Yamagata E et al. Increased release of glucuronoxylomannan antigen and induced phenotypic changes in Trichosporon asahii by repeated passage in mice. J. Med. Microbiol. 2002 51 423 432.